BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

ROYAL BANK OF CANADA's Holding History (CIK: 0001000275)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 10,000 Value ($000) $10 Avg Close — Range —
Q1 2024
Shares 6,737,000 Value ($000) $6,616 Avg Close — Range —
Q4 2023
Shares 6,689,000 Value ($000) $6,593 Avg Close — Range —
Q3 2023
Shares 19,020,000 Value ($000) $18,450 Avg Close — Range —
Q2 2023
Shares 16,822,000 Value ($000) $16,524 Avg Close — Range —
Q1 2023
Shares 17,336,000 Value ($000) $17,786 Avg Close — Range —
Q4 2022
Shares 18,585,000 Value ($000) $19,724 Avg Close — Range —
Q3 2022
Shares 18,695,000 Value ($000) $18,612 Avg Close — Range —
Q2 2022
Shares 21,655,000 Value ($000) $21,438 Avg Close — Range —
Q1 2022
Shares 31,315,000 Value ($000) $31,300 Avg Close — Range —
Q4 2021
Shares 31,864,000 Value ($000) $33,317 Avg Close — Range —
Q3 2021
Shares 31,639,000 Value ($000) $32,508 Avg Close — Range —
Q2 2021
Shares 27,139,000 Value ($000) $28,124 Avg Close — Range —
Q1 2021
Shares 5,545,000 Value ($000) $5,675 Avg Close — Range —
Q4 2020
Shares 424,000 Value ($000) $455 Avg Close — Range —
Q3 2020
Shares 424,000 Value ($000) $445 Avg Close — Range —
Q2 2020
Shares 520,000 Value ($000) $638 Avg Close — Range —
Q1 2020
Shares 700,000 Value ($000) $731 Avg Close — Range —
Q3 2019
Shares 2,000 Value ($000) $2 Avg Close — Range —
Q4 2018
Shares 250,000 Value ($000) $248 Avg Close — Range —
Q4 2017
Shares 34,300,000 Value ($000) $34,171 Avg Close — Range —
Q3 2017
Shares 26,150,000 Value ($000) $26,542 Avg Close — Range —